{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:18:16Z","timestamp":1790205496883,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.eplepsyres.2011.01.016","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T02:55:23Z","timestamp":1306119323000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy"],"prefix":"10.1016","volume":"95","author":[{"given":"Medine Idrizoglu","family":"Gulcebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Ozkaynakc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Zafer","family":"Goren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezzan Gulhan","family":"Aker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz Y\u0131lmaz","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eplepsyres.2011.01.016_bib0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ftd.0000179854.16846.67","article-title":"The pharmacokinetics and interactions of new antiepileptic drugs: an overview","volume":"27","author":"Bialer","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2006.10.008","article-title":"Progress report on new antiepileptic drugs: a summary of the eight Eilat Conference (EILAT VIII)","volume":"73","author":"Bialer","year":"2007","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.eplepsyres.2011.01.016_bib0015","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/hep.20131","article-title":"Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT 1A4","volume":"39","author":"Ehmer","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WCO.0b013e328328f276","article-title":"Genetic basis for idiosyncratic reactions to antiepileptic drugs","volume":"2","author":"Franciotta","year":"2009","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2011.01.016_bib0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FTD.0b013e318178e2a9","article-title":"Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium","volume":"30","author":"Franco","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0030","first-page":"380","article-title":"Lamotrigine, interaction with other drugs","volume":"vol. 5","author":"Garnett","year":"2002"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0090-9556(25)07355-6","article-title":"Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein","volume":"24","author":"Green","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0090-9556(24)15257-9","article-title":"Retigabine N-glucuronidation and its potential role in enterohepatic circulation","volume":"27","author":"Hiller","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.eplepsyres.2011.01.016_bib0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.eplepsyres.2011.01.016_bib0050","first-page":"31","article-title":"Lack of association between L48V polymorphism in the UGT1A4 gene and lamotrigine-induced Rash","volume":"10","author":"Kim","year":"2006","journal-title":"J. Korean Epilepsy Soc."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4347(96)00453-7","article-title":"New micromethod for the determination of the lamotrigine in human plasma by high-performance liquid chromatography","volume":"691","author":"Londero","year":"1997","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0060","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5414\/CPP47752","article-title":"Population pharmacokinetics of lamotrigine in patients with epilepsy","volume":"47","author":"Milovanovic","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0300-483X(02)00449-3","article-title":"Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance","volume":"181\u2013182","author":"Miners","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/dmd.104.002576","article-title":"UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation","volume":"33","author":"Mori","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.seizure.2007.11.017","article-title":"Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites","volume":"17","author":"\u00d6hman","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0080","series-title":"Antiepileptic Drugs","first-page":"877","article-title":"Lamotrigine: absorption, distribution and excretion","author":"Parsons","year":"1995"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/000456329903600102","article-title":"New antiepileptic drugs","volume":"36","author":"Patsalos","year":"1999","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0095","series-title":"Anti-epileptic Drug Interactions: A Clinical Guide","author":"Patsalos","year":"2005"},{"issue":"9","key":"10.1016\/j.eplepsyres.2011.01.016_bib0100","first-page":"7","article-title":"The clinical pharmacokinetics of the new antiepileptic drugs","volume":"40","author":"Perruca","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.seizure.2008.05.009","article-title":"Smoking reduces serum levels of lamotrigine","volume":"17","author":"Reinsberger","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","article-title":"Oral contraceptives reduce lamotrigine plasma levels","volume":"61","author":"Sabers","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.eplepsyres.2011.01.016_bib0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2133\/dmpk.20.144","article-title":"Genetic variations and haplotypes of UGT 1A4 in a Japanese population","volume":"20","author":"Saeki","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.eplepsyres.2011.01.016_bib0125","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/bcr1539","article-title":"Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants","volume":"8","author":"Sun","year":"2006","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.eplepsyres.2011.01.016_bib0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.59.2.251","article-title":"Lamotrigine clearance during pregnancy","volume":"59","author":"Tran","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0300-483X(02)00513-9","article-title":"Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour","volume":"183","author":"Tricker","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0140","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1528-1157.1997.tb01489.x","article-title":"Lamotrigine in pregnancy and lactation: a case report","volume":"38","author":"Tomson","year":"1997","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.eplepsyres.2011.01.016_bib0150","first-page":"82","article-title":"Effect of valproate on the pharmacokinetics of lamotrigine at steady state","volume":"33","author":"Yau","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.01.016_bib0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.1992.tb04079.x","article-title":"Sodium valproate acutely inhibits lamotrigine metabolism","volume":"33","author":"Yuen","year":"1992","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:25:04Z","timestamp":1760275504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121111000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0920121111000350"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.01.016","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}